Company intelligence / Profile preview

AIQ Solutions

Madison, Wisconsin, United Statesaiq-solutions.com ↗

Ownership: Private
Employees: ~30
Development stage: Commercial

Overview

TRAQinform IQ has been validated in multiple clinical trials and is cleared for use by the US FDA and Australian TGA. It provides quantitative analysis of individual lesions from serial PET/CT scans, enabling oncologists to optimize therapy regimens for late-stage/metastatic cancer patients. The technology has demonstrated value in both large academic centers and community hospitals. No direct therapeutic outcomes are reported since the product is a diagnostic/decision-support tool.

Therapeutic areas: OncologyOther
Modalities: Device (Software medical device)
Industry: Medical Imaging

Partnerships

Blackford Analysis

Beyond the preview

Go deeper on AIQ Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AIQ Solutions.

Explore the full profile